Renal Cancer - Results from #4940

Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report September 28, 2017

Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors September 28, 2017

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma September 27, 2017

Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype September 27, 2017

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4 September 27, 2017

Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance September 27, 2017

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma September 26, 2017

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease September 26, 2017

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era September 26, 2017

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium September 26, 2017

The impact of lymph node dissection and positive lymph nodes on cancer specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy September 25, 2017

Immunomodulation by entinostat in renal cell carcinoma patients receiving high dose interleukin 2: a multicenter, single-arm, phase 1/2 trial (NCI-CTEP#7870) September 25, 2017

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial September 25, 2017

Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases September 25, 2017

Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma September 25, 2017

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma September 22, 2017

Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study September 22, 2017

Association between coffee consumption and risk of renal cell carcinoma: A Meta-analysis September 22, 2017

Emerging Immunotherapy in Advanced Renal Cell Carcinoma September 21, 2017

Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy September 21, 2017

Page 248 of 456